NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE was delisted on the 10th of May, 2024.
53 hedge funds and large institutions have $50.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.
132% more call options, than puts
Call options by funds: $868K | Put options by funds: $374K
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
17% more capital invested
Capital invested by funds: $43.1M → $50.6M (+$7.51M)
2% more funds holding
Funds holding: 52 → 53 (+1)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Top Buyers
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$1.15M |
| 2 |
Millennium Management
New York
|
-$438K |
| 3 |
Goldman Sachs
New York
|
-$386K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$224K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
SM
52
Sabby Management
Miami Beach,
Florida
| $417 | -$224K | -73 | -37% |
|
53
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $126 | +$9.2K | +3 | +9% |
|
|
BRWA
54
B. Riley Wealth Advisors
Boca Raton,
Florida
| $11 | +$9.2K | +3 | New |
|
|
55
Citadel Advisors
Miami,
Florida
| – | -$68K | -23 | Closed |
|
|
SO
56
STRS Ohio
Columbus,
Ohio
| – | -$52K | -18 | Closed |
|
57
Barclays
London,
United Kingdom
| – | -$11K | -4 | Closed |
|
58
BNP Paribas Financial Markets
Paris,
France
| – | -$10.7K | -4 | Closed |
|
NBSE Hedge Fund Activity: Q4 2014 in Review
53 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q4 2014, worth a combined $50.6M — up 17% from $43.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NBSE positions and 4 closed out — a net gain of 3 holders — while 17 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $886K. The largest seller was Visium Asset Management, cutting an estimated $1.15M.
- 53 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q4 2014, up from 52 in Q3 2014.
- Funds reported $50.6M of NeuBase Therapeutics, Inc. Common Stock stock for Q4 2014, up 17% quarter-over-quarter.
- 7 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q4 2014 and 4 closed out, a net change of +3 holders.
- The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $886K added.
- The largest NeuBase Therapeutics, Inc. Common Stock seller in Q4 2014 was Visium Asset Management, an estimated $1.15M sold.
Based on aggregated 13F filings for Q4 2014.